Welcome to
RBP World!
Drugs target to TFRC
| Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
|---|---|---|---|---|---|---|
| A27.15 | Antibody | leukemia | Transferrin receptor protein 1 antagonist | 1.0 | Completed | ClinicalTrials |
| PABINAFUSP ALFA | Protein | mucopolysaccharidosis type 2 | Transferrin receptor binding agent | 3.0 | Recruiting | ClinicalTrials |
| PABINAFUSP ALFA | Protein | mucopolysaccharidosis type 2 | Transferrin receptor binding agent | 1.0 | Completed | ClinicalTrials |
| E2.3 | Antibody | multiple myeloma | Transferrin receptor inhibitor | 1.0 | Completed | ClinicalTrials |
| E2.3 | Antibody | chronic myeloproliferative disorder | Transferrin receptor inhibitor | 1.0 | Completed | ClinicalTrials |
| A27.15 | Antibody | multiple myeloma | Transferrin receptor protein 1 antagonist | 1.0 | Completed | ClinicalTrials |
| E2.3 | Antibody | leukemia | Transferrin receptor inhibitor | 1.0 | Completed | ClinicalTrials |
| PABINAFUSP ALFA | Protein | mucopolysaccharidosis type 2 | Transferrin receptor binding agent | 2.0 | Active, not recruiting | ClinicalTrials |
| E2.3 | Antibody | myelodysplastic syndrome | Transferrin receptor inhibitor | 1.0 | Completed | ClinicalTrials |
| A27.15 | Antibody | chronic myeloproliferative disorder | Transferrin receptor protein 1 antagonist | 1.0 | Completed | ClinicalTrials |
| PABINAFUSP ALFA | Protein | mucopolysaccharidosis type 2 | Transferrin receptor binding agent | 3.0 | Not yet recruiting | ClinicalTrials |
| PABINAFUSP ALFA | Protein | mucopolysaccharidosis type 2 | Transferrin receptor binding agent | 2.0 | Completed | ClinicalTrials |
| A27.15 | Antibody | myelodysplastic syndrome | Transferrin receptor protein 1 antagonist | 1.0 | Completed | ClinicalTrials |